Deleterious passenger mutations accumulate in most tumors

Christopher McFarland

Assistant Professor

Chris obtained a PhD from Harvard University in Biophysics under the guidance of Leonid Mirny, studying the effects of deleterious passenger mutations in cancer. As a postdoc, Chis helped develop a high-throughput technology to study combinatorial tumor suppressor losses in mice and their effects on clonal dynamics.